{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:13:34Z","timestamp":1793420014849,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bioorg.2020.103955","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T11:25:06Z","timestamp":1589973906000},"page":"103955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents"],"prefix":"10.1016","volume":"100","author":[{"given":"Singireddi","family":"Srinivasarao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adinarayana","family":"Nandikolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaroju","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustynowicz-Kopec","family":"Ewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"G\u0142ogowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaram","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banoth Karan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankaranarayanan","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravani","family":"Pulya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kondapalli Venkata Gowri Chandra","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103955_b0005","unstructured":"https:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"10.1016\/j.bioorg.2020.103955_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9780470187333.ch1","article-title":"Chemistry of Heterocyclic Compounds: Condensed Pyrazines","volume":"35","author":"Cheeseman","year":"1979","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.bioorg.2020.103955_b0015","unstructured":"A.E.A. Porter, in: A.R. Katrizky, C.W. Rees (Eds.), Comprehensive Heterocyclic Chemistry, vol. 3, Pergamon Press, New York, 1984."},{"issue":"5","key":"10.1016\/j.bioorg.2020.103955_b0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0223-5234(02)01346-6","article-title":"Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity","volume":"37","author":"Carta","year":"2002","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2020.103955_b0025","first-page":"927","article-title":"Derivados de 1,4-di-N-\u00f3xido de quinoxalinayenfermedades olvidadas","volume":"73","author":"Vicente","year":"2007","journal-title":"A. An. R. Acad. Nac. Farm."},{"issue":"14","key":"10.1016\/j.bioorg.2020.103955_b0030","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1016\/j.bmcl.2004.04.088","article-title":"N\u2032-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure\u2013activity relationships","volume":"14","author":"Aguirre","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.bioorg.2020.103955_b0035","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.bmc.2006.04.041","article-title":"Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N-1, N4-dioxide derivatives by complexation with vanadium","volume":"14","author":"Urquiola","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103955_b0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2003.11.008","article-title":"Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides","volume":"39","author":"Carta","year":"2004","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2020.103955_b0045","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0968-0896(01)00163-8","article-title":"Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide","volume":"9","author":"Ganley","year":"2001","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2020.103955_b0050","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1016\/j.bmcl.2016.01.066","article-title":"Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents","volume":"26","author":"Pan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2020.103955_b0055","first-page":"55","article-title":"New Quinoxaline 1,4-Di-N-oxides for Treatment of Tuberculosis","volume":"49","author":"Sainza","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bioorg.2020.103955_b0060","doi-asserted-by":"crossref","unstructured":"M. A. Ortega, Y. Sainz, M. E. Montoya, A. L\u00f3pez de Cer\u00e1in, and A. Monge, Die Pharmazie, Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides, 54 (1) 1999 24-25. 10.1002\/chin.199921160.","DOI":"10.1002\/chin.199921160"},{"issue":"10","key":"10.1016\/j.bioorg.2020.103955_b0065","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0968-0896(03)00119-6","article-title":"Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives","volume":"11","author":"Zarranz","year":"2003","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2020.103955_b0070","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0223-5234(03)00137-5","article-title":"Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents","volume":"38","author":"Jaso","year":"2003","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2020.103955_b0075","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1021\/jm049952w","article-title":"Synthesis of New Quinoxaline-2-carboxylate 1,4-Dioxide Derivatives as anti-Mycobacterium tuberculosis Agents","volume":"48","author":"Jaso","year":"2005","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2020.103955_b0080","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1016\/j.electacta.2011.01.030","article-title":"1,4-Di-N-oxide quinoxaline-2-carboxamide: Cyclic voltammetry and relationship between electrochemical behavior, structure and anti-tuberculosis activity","volume":"56","author":"Moreno","year":"2011","journal-title":"Electrochim. Acta"},{"issue":"12","key":"10.1016\/j.bioorg.2020.103955_b0085","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.bmcl.2011.04.072","article-title":"New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents","volume":"21","author":"Torres","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2020.103955_b0090","first-page":"196","article-title":"Quinoxaline 1,4-di-N-Oxide and the Potential for Treating Tuberculosis, Infectious Disorders \u2013 Drug","volume":"11","author":"Vicente","year":"2011","journal-title":"Targets."},{"issue":"3","key":"10.1016\/j.bioorg.2020.103955_b0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bmcl.2013.12.095","article-title":"Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents","volume":"24","author":"Zhang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bioorg.2020.103955_b0100","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1021\/jm800149m","article-title":"A Copper(I)-Catalyzed 1,2,3-Triazole Azide\u2212Alkyne Click Compound Is a Potent Inhibitor of a Multidrug-Resistant HIV-1 Protease Variant","volume":"51","author":"Giffin","year":"2008","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103955_b0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C4OB01758G","article-title":"Synthesis and antifungal activity of 1,2,3-triazole phenylhydrazone derivatives","volume":"13","author":"Dai","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2020.103955_b0110","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1021\/jm00161a022","article-title":"Studies on 1,2,3-triazoles. 13. (Piperazinylalkoxy)-[1]benzopyrano[2,3-d]-1,2,3-triazol-9(1H)-ones with combined H1-antihistamine and mast cell stabilizing properties","volume":"29","author":"Buckle","year":"1986","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2020.103955_b0115","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Kolb","year":"2003","journal-title":"Drug Discov. Today."},{"issue":"4","key":"10.1016\/j.bioorg.2020.103955_b0120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/cbdd.12527","article-title":"Triazole: A Promising Antitubercular Agent","volume":"86","author":"Keri","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2020.103955_b0125","doi-asserted-by":"crossref","unstructured":"J. Xie, C.T. Seto, A two stage click-based library of protein tyrosine phosphatase inhibitors, Bioorg. Med. Chem. 15(1) (2007) 15 458-473. 10.1016\/j.bmc.2006.09.036.","DOI":"10.1016\/j.bmc.2006.09.036"},{"issue":"6","key":"10.1016\/j.bioorg.2020.103955_b0130","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.ejmech.2011.03.039","article-title":"New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents","volume":"465","author":"Thomas","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2020.103955_b0135","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.bmcl.2016.04.015","article-title":"Click-based synthesis and antitubercular evaluation of novel dibenzo[b, d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages","volume":"26","author":"Pulipati","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103955_b0140","doi-asserted-by":"crossref","unstructured":"H.N. Nagesh, K.M. Naidu, D. Harika Rao, J.P. Sridevi, D. Sriram, P. Yogeeswari, K.V. G.C. Sekhar, Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents, Bioorg. Med. Chem. Lett., 23 (24) 2013, 6805-6810. 10.1016\/j.bmcl.2013.10.016.","DOI":"10.1016\/j.bmcl.2013.10.016"},{"issue":"17","key":"10.1016\/j.bioorg.2020.103955_b0145","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/jm2003624","article-title":"Novel 1,2,3-Triazole Derivatives for Use against Mycobacterium tuberculosis H37Rv (ATCC 27294) Strain","volume":"54","author":"Boechat","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103955_b0150","doi-asserted-by":"crossref","unstructured":"L.M. Lima, D.N. do Amaral, Beirut Reaction and its Application in the Synthesis of Quinoxaline-N,N\u2019-Dioxides Bioactive Compounds, Rev. Virtual Quim, 5(67), 1075-1100. 10.5935\/1984-6835.20130079.","DOI":"10.5935\/1984-6835.20130079"},{"issue":"16","key":"10.1016\/j.bioorg.2020.103955_b0155","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1016\/j.bmcl.2017.07.008","article-title":"Sekhar, Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents","volume":"27","author":"Aziz","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103955_b0160","doi-asserted-by":"crossref","unstructured":"K.M. Naidu, S. Srinivasarao, N. Agnieszka, A. Ewa, M.M. Krishna Kumar and K.V.G.C. Sekhar, Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles\/indole)-piperazin-1-yl\/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives, Bioorg. Med. Chem. Lett., 26(9) (2016) 2245-2250,.10.1016\/j.bmcl.2016.03.059.","DOI":"10.1016\/j.bmcl.2016.03.059"},{"key":"10.1016\/j.bioorg.2020.103955_b0165","unstructured":"J.D. Turnidge , J.H. Jorgensen, Manual of Clinical Microbiology. ed 7. Washington: American Society for Microbiology; 1999. Antimicrobial susceptibility testing: general considerations; pp. 1469\u20131473."},{"issue":"3","key":"10.1016\/j.bioorg.2020.103955_b0170","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.103955_b0175","unstructured":"Schr\u00f6dinger Release 2019-1: QikProp, Schr\u00f6dinger, LLC, New York, NY, 2019."},{"key":"10.1016\/j.bioorg.2020.103955_b0180","volume":"2\u20134","author":"Manual","year":"2015","journal-title":"QikProp Descriptors and Properties PISA"},{"issue":"16","key":"10.1016\/j.bioorg.2020.103955_b0185","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances","volume":"14","author":"Lionta","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103955_b0190","doi-asserted-by":"crossref","unstructured":"R.A. Friesner, J.L. Banks, R.B. Murphy, T.A. Halgren, J.J. Klicic, D.T. Mainz, M.P. Repasky, E.H. Knoll, M. Shelley, J.K. Perry and D.E. Shaw, Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy, J. Med. Chem. 47 (7) (2004) 1739\u20131749. 10.1021\/jm0306430.","DOI":"10.1021\/jm0306430"},{"issue":"1","key":"10.1016\/j.bioorg.2020.103955_b0195","first-page":"165","article-title":"Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects","volume":"124","author":"Prakruti","year":"2018","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819322564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819322564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:09:12Z","timestamp":1758614952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819322564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":39,"alternative-id":["S0045206819322564"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103955","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103955"}}